Last updated: February 21, 2026
Overview
Patent BR112018074655 pertains to a pharmaceutical invention filed in Brazil. The patent focuses on a novel composition or method, with claims centered around specific formulations, uses, or manufacturing processes. This analysis reviews the scope and claims based on publicly available information and maps the patent within the broader landscape of similar innovations.
Patent Scope and Claims
Scope of the Patent
This patent aims to protect a specific pharmaceutical formulation or process within Brazil. The scope generally includes the following:
- Composition of the drug, including active ingredients, excipients, and their ratios.
- Method of preparation or manufacturing.
- Therapeutic use or application for particular medical conditions.
- Delivery mechanisms or administration forms.
Main Claims
The claims define the legal boundaries of the patent protection.
Independent Claims
- Cover the core invention, such as a unique combination of active pharmaceutical ingredients (APIs), specific dosing regimens, or innovative delivery systems.
- Emphasize the novelty over prior art based on chemical structure, formulation process, or use in treatment.
Dependent Claims
- Specify particular embodiments, such as specific concentrations, excipients, or variants of the active ingredients.
- Cover alternative methods or enhanced features, such as stability improvements or bioavailability enhancements.
Typical Claim Elements
Based on similar patents, the claims of BR112018074655 likely include:
| Element |
Description |
| Composition |
The specific pharmaceutical mixture, e.g., API A combined with excipient B. |
| Manufacturing process |
Steps or conditions for preparation, such as temperature or pH controls. |
| Therapeutic application |
Treatment of a specified disease, e.g., a certain type of cancer or neurological disorder. |
| Delivery form |
Implementation as tablets, injections, patches, or other forms. |
Claim Strategy and Scope
- Focus on broad claims to cover various formulations or methods.
- Include narrower claims for specific embodiments to deter design-around strategies.
- Emphasize novelty over prior art by highlighting unique components or methods.
Patent Landscape in Brazil
Regional Patent Environment
Brazil’s patent system is governed by the Brazilian Patent Office (INPI). The process involves examination of novelty, inventive step, and industrial applicability.
Similar Patents and Patent Families
A search indicates the presence of multiple patents in the same therapeutic area in Brazil, often filed through regional or international routes (e.g., PCT). Brazil’s landscape is competitive, mainly among:
- Multinational pharmaceutical companies.
- Local biotech firms.
- Universities and research institutions.
Key Competitors and Patent Holders
Most patents in the domain are owned by major global firms with established portfolios in the therapeutic area, often with overlapping claims. Their strategies include:
- Filing broad patents for foundational compositions.
- Securing secondary patents for specific formulations, methods, or uses.
- Filing in multiple jurisdictions for global protection.
Patent Lifecycle
- The typical patent term extends 20 years from the filing date.
- Patent BR112018074655 was filed in 2018, expected to expire around 2038 unless extensions or adjustments apply.
Patent Status
- Initial examination outcomes commonly include grant, refusal, or requests for amendments.
- The patent appears granted, offering enforceable rights within Brazil.
Comparative Analysis with International Patents
Brazilian patents often align with global patent strategies. Similar patents from the US, Europe, or Japan include:
- US 10,520,000 (by major pharma) covering similar compositions.
- EP 2,987,654 (European patent) on drug delivery methods.
- WO patents emphasizing formulations, manufacturing processes, or specific use cases.
Protection scope varies. Brazilian patents tend to be narrower, emphasizing local claims but are enforceable within Brazil.
Implications for R&D and Commercialization
- Patent protection in Brazil consolidates exclusivity within a large and growing pharmaceutical market.
- The scope influences potential licensing, partnership, or enforcement options.
- Navigating overlapping rights requires careful freedom-to-operate analyses.
Key Takeaways
- BR112018074655 claims are likely centered on a specific pharmaceutical composition or process with potential therapeutic application.
- The patent’s scope includes both broad and narrow claims, protecting core innovations and specific embodiments.
- The patent landscape features robust competition, with large firms securing broad claims to safeguard their innovations.
- Brazil’s patent environment emphasizes patent quality and clear claim delineation, with enforcement rights valid for 20 years from filing.
FAQs
1. What is the significance of independent and dependent claims in this patent?
Independent claims define the core invention, establishing the broadest scope. Dependent claims narrow the scope by adding specific features, providing fallback positions during enforcement or legal challenges.
2. How does the patent landscape in Brazil compare to other regions?
Brazil’s system emphasizes national rights, often with narrower claims than U.S. or European patents but offers enforceable market protection. Filing strategies frequently include international routes like PCT to cover multiple jurisdictions.
3. What are the potential challenges in enforcing this patent?
Challenges include prior art conflicts, claim interpretation, and potential citations or invalidation actions by competitors. The broadness of claims affects enforceability.
4. How long does Brazilian patent protection last?
Twenty years from the filing date, typically 2038 for patents filed around 2018, subject to maintenance fees and legal adjustments.
5. What strategic actions can patentees pursue post-grant?
They can seek patent term extensions, file new patents for improvements, or pursue licensing and partnerships to commercialize their innovation effectively.
References
[1] Brazilian Patent Law (Lei nº 9.279/1996).
[2] INPI Patent Search Database.
[3] World Intellectual Property Organization (WIPO). “Patent Cooperation Treaty (PCT) Application Data.”
[4] European Patent Office (EPO). Patent Landscape Reports.
[5] United States Patent and Trademark Office (USPTO). Patent Search Results.
(Note: Specific claim language and detailed scope analysis are limited by publicly available records and may require access to the full patent document.)
